A FEASIBILITY STUDY OF VINORELBINE AND BEVACIZUMAB IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Kaburaki, Kyohei [1 ]
Isobe, Kazutoshi [1 ]
Yamamoto, Ai [1 ]
Tochigi, Naobumi [2 ]
Hata, Yoshinobu [2 ]
Shibuya, Kazutoshi [2 ]
Iyoda, Akira [2 ]
Homma, Sakae [2 ]
机构：
[1] Toho Univ, Omori Med Ctr, Tokyo, Japan
[2] Toho Univ, Sch Med, Tokyo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
Bevacizumab; Previously treated; combination therapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.10-052
引用
收藏
页码：S887 / S887
页数：1
相关论文
共 50 条
  • [1] THE EFFICACY AND TOXICITY OF CHEMOTHERAPY WITH BEVACIZUMAB FOR PREVIOUSLY TREATED PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Itotani, R.
    Kitajima, T.
    Inoue, D.
    Takamatsu, K.
    Ishitoko, M.
    Marumo, S.
    Sakuramoto, M.
    Fukui, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S47 - S47
  • [2] A prospective cohort study of patients with non-squamous non-small cell lung cancer treated with bevacizumab
    Naoki, Katsuhiko
    Takeda, Yuichiro
    Soejima, Kenzo
    Arai, Daisuke
    Naka, Go
    Nagase, Seisuke
    Arirnura, Ken
    Kanemura, Toshinori
    Ohhira, Tatsuo
    Ikeda, Norihiko
    [J]. ONCOLOGY LETTERS, 2017, 13 (05) : 3285 - 3290
  • [3] A PROSPECTIVE COHORT STUDY OF NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH BEVACIZUMAB
    Naoki, Katsuhiko
    Soejima, Kenzo
    Nagase, Seisuke
    Kanemura, Toshinori
    Ohhira, Tatsuo
    Takeda, Yuichiro
    Ikeda, Norihiko
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S868 - S868
  • [4] PHASE II TRIAL OF BEVACIZUMAB PLUS DOCETAXEL IN PATIENTS WITH PREVIOUSLY TREATED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Ohyanagi, F.
    Kudo, K.
    Yanagitani, N.
    Horiike, A.
    Horai, T.
    Nishio, M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 441 - 442
  • [5] Safety and Efficacy of Apatinib in Patients with Previously Heavily Treated Advanced Non-Squamous Non-Small Cell Lung Cancer
    Wu, Feng Ying
    Zhang, Shi Jia
    Ren, Sheng Xiang
    Zhou, Caicun
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1286 - S1287
  • [6] Phase II Study of Docetaxel-plus-Bevacizumab Combination Therapy in Patients Previously Treated for Advanced Non-squamous Non-small Cell Lung Cancer
    Ohyanagi, Fumiyoshi
    Yanagitani, Noriko
    Kudo, Keita
    Kawano, Yuko
    Sakatani, Toshio
    Tanimoto, Azusa
    Nishizawa, Hironari
    Horiike, Atsushi
    Hagiwara, Sachiko
    Horai, Takeshi
    Nishio, Makoto
    [J]. ANTICANCER RESEARCH, 2014, 34 (09) : 5153 - 5158
  • [7] The efficacy and safety of pemetrexed plus bevacizumab in previously treated patients with advanced non-squamous non-small cell lung cancer (ns-NSCLC)
    Ding, Lingyu
    Liu, Kejun
    Jiang, Zhelong
    Chen, Qi
    Zhou, Ningning
    Liang, Ying
    Gao, Hongfei
    Hong, Xiangchan
    Wu, Haiying
    [J]. TUMOR BIOLOGY, 2015, 36 (04) : 2491 - 2499
  • [8] Pemetrexed versus vinorelbine treatment of advanced non-squamous non-small cell lung cancer in elderly patients
    Chen, Yongshun
    Wen, Qinglian
    Liu, Hao
    Ao, Rui
    Wu, Xiaoyuan
    Guo, Leiming
    Wang, Wen
    He, Chunyu
    Wang, Jianhua
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (03) : 553 - 557
  • [9] Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer
    Lal, R.
    Hillerdal, G. N.
    Shah, R. N. H.
    Crosse, B.
    Thompson, J.
    Nicolson, M.
    Vikstrom, A.
    Potter, V. A.
    Visseren-Grul, C.
    Lorenzo, M.
    D'yachkova, Y.
    Bourayou, N.
    Summers, Y. J.
    [J]. LUNG CANCER, 2015, 89 (02) : 154 - 160
  • [10] Feasibility of cisplatin/pemetrexed with 15 mg/kg bevacizumab for the treatment of patients with advanced non-squamous non-small cell lung cancer
    Hirai, Fumihiko
    Seto, Takashi
    Inamasu, Eiko
    Shimokawa, Mototsugu
    Toyokawa, Gouji
    Yoshida, Tsukihisa
    Nosaki, Kaname
    Takenaka, Tomoyoshi
    Yamaguchi, Masafumi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    [J]. ONCOLOGY LETTERS, 2015, 9 (06) : 2577 - 2582
12345